<unk> (oral) is a hemostatic agent that is FDA approved for the treatment of surgical complications following heart surgery (with or without cardiac bypass procedures) and portacaval shunt; hematological disorders such as amegakaryocytic thrombocytopenia (accompanying aplastic anemia); acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix.   Common adverse reactions include abdominal pain, nausea, vomiting, diarrhea, headache dizziness, confusion, hallucinations, blurred vision, and tinnitus.
Aminocaproic acid 
Prothrombin complex concentrate
Platelet rich plasma
Protamine Sulfate
Asfotase alfa
Vitamin K
Recombinant factor VIIa
Hirudin